WEDNESDAY, Oct. 13, 2004 (HealthDayNews) -- A therapy designed to boost the body's immune system could reduce the risk of a second attack of symptoms related to multiple sclerosis, according to an article in the October issue of The Archives of Neurology.
Multiple sclerosis is a chronic inflammatory disease in which the body's myelin -- the material that covers and insulates nerve cells in the brain and spinal cord -- begins to deteriorate. This causes impairment of motor, sensory, visual and cognitive funcion.
Israeli researchers found that intravenous immunoglobulin therapy applied after the first signs of MS significantly reduced the probability of developing clinically definite multiple sclerosis.
Patients receiving the therapy also suffered fewer brain lesions.
The research was conducted by doctors at the Sheba Medical Center in Tel-Hoshomer.
More information
The National Institutes of Health have more about multiple sclerosis.
